Thalassemia Data Collection and Blood Safety Monitoring
Blood Safety Monitoring
People with inherited blood disorders such as thalassemia, Diamond-Blackfan anemia, and sickle cell disease (SCD) often require frequent blood transfusions to remain healthy. In the United States, blood donations are screened for various viruses that can cause infections. Additionally, blood donors can be excluded from donating based on their responses to questionnaires to determine their risk of having a transfusion-transmissible infection (an infection that can be passed to another person through a blood transfusion). These mechanisms work together to keep the risk of obtaining a transfusion-transmitted infection extremely low.
Blood Safety Monitoring for People with Blood Disorders
Blood Safety Monitoring for People with Blood Disorders is a new project that allows the CDC to continue to monitor people who receive routine blood transfusions. However, this project will monitor not only patients with thalassemia but also those with sickle cell disease, Diamond-Blackfan Anemia, and other non-cancer-related blood disorders. Expanding this monitoring to other groups of people that have frequent transfusions will increase the likelihood that a new or developing threat to the safety of blood can be found rapidly. Through this new Blood Safety Monitoring project, CDC aims to:
- Better understand the risks of transfusion-related health problems and illness due to the spread of infected blood through transfusions
- Better understand rare blood types and blood banking practices
- Monitor the rates of transfusion-related health problems
- Develop strategies to prevent the health problems that often occur from having regular blood transfusions [such as every 4–6 weeks] over a long period of time
- Find ways to address new or re-emerging infectious diseases (diseases that have increased in number within the past 2 decades or threaten to increase in the future)
CDC provides funding through a cooperative agreement to 4 awardees each of whom have access to at least 250 patients with non-cancer-related blood disorders who receive at least one transfusion per year. This project helps CDC address the Healthy People 2020 objective BDBS-18: reduce the proportion of persons who develop adverse events resulting from the use of blood and blood products.
Thalassemia Data and Blood Specimen Collection Project
Thalassemia patients are at high risk for infection through blood transfusion because of their need to be treated with blood products for their condition. The CDC created the Thalassemia Data and Blood Specimen Collection Project in 2004 to quickly find known and developing infections that might spread through blood transfusion and be a potential threat to these high risk patients. This project focused on patients who received care at seven CDC-funded Thalassemia Treatment Centers (TTCs). In addition to testing for the presence of hepatitis and HIV, viruses known to have been transmitted in blood in the past, TTC participants were also tested for a new emerging virus - the West Nile Virus. This project concluded in 2012.
- Page last reviewed: September 14, 2015
- Page last updated: January 27, 2014
- Content source: